OLAPLEX acquires Boston biotech company Purvala Bioscience
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St up after tech selloff as yields retreat; Moderna surges
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
OLAPLEX Acquires Biotech Company Purvala
August 26, 2025 6:55 AM EDTTen years after launch, OLAPLEXs first acquisition demonstrates its commitment to product innovation
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare.
Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with... More
